Latest stories

  • in

    Combination therapy with oral fluvoxamine and inhaled budesonide significantly Cuts Severe Disease in COVID-19

    Researchers have found in a randomized controlled trial that treatment with oral antidepressant fluvoxamine plus inhaled budesonide among high-risk outpatients with early COVID-19 reduced the incidence of severe disease requiring advanced care. Previous studies evaluated these drugs independently. The combined effect seems to offer benefits over individual use of each drug. The findings are published […] More